Trial Details

RECRUITING
Basic Information
Clinical ID c95
Identifier NCT07181525
Trial Title Construction and Validation of a Predictive Model for the Efficacy of Different Biologics in Inflammatory Bowel Disease
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Inflamatory Bowel Disease
Interventions DRUG: anti-cytokine antibodies|DRUG: anti-integrin antibodies
Participant Information
Sponsor Peking University First Hospital
City Beijing
Country/Region China
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type OBSERVATIONAL
Phase NULL
Time Information
Start Date 2025-08-15
Primary Completion Date 2026-07-01
Completion Date 2026-12-31